Mark Cockett

Doer
DISC Type : ds

President & Chief Scientific Officer at Paratus Sciences

New Haven, Connecticut, United States

Overview

Mark Cockett is the President and Chief Scientific Officer at Paratus Sciences, a company decoding evolution to develop new medicines. With over 30 years of experience, he has delivered numerous antiviral drugs to market, including atazanavir and entecavir. He holds a Ph.D. in molecular and cell biology from The Open University and is described by colleagues as a "great people leader" and one of the "smartest scientists" theyve worked with.

There is no publicly available information about his personal life or interests outside of his extensive professional career in the pharmaceutical and biotech industries. His work demonstrates a deep commitment to scientific discovery and addressing unmet medical needs through innovative research and development strategies.

He is leading research at Paratus Sciences that leverages the unique evolutionary traits of bats, such as their resistance to disease and cancer, to discover novel therapeutics for human diseases.

Personality Overview

Deliberate Doer

Strategic Planner

Results Focused

They are very professional in their approach and can weigh multiple perspectives together.  They might take some time to make their mind up but once they do, they don't change it easily. They exhibit a rare combination of being result-oriented but patient at the same time.

Topics They Care About

Bat-Inspired Therapeutics
His company, Paratus Sciences, is focused on translating the unique biological resilience of bats into first-in-class medicines for human diseases.
Antiviral Drug Discovery
He has a long and successful track record, having supported the development of multiple marketed antiviral drugs for HIV, HBV, and HCV.
R&D Strategy
His career includes leading discovery organizations at ViiV Healthcare and Bristol-Myers Squibb, driving the strategy for new drug pipelines.

Media Appearances

Mark has no verified media appearances

Work History

4-2025
President & Chief Scientific Officer at Paratus Sciences
9-2024
Entrepeneur-In-Residence at Yale Ventures
5-2022 - 7-2024
CEO and President R&D at Alphina Therapeutics
3-2022
President at MIC Scientific Consulting
2-2016 - 2-2022
VP, Head of Discovery at ViiV Healthcare

Education

Ph.D. from The Open University
Bachelor of Science - BS from Institute of Biology - Royal Society of Biology

More Information

Social Presence :

Prographics :

Exp : 41 Location : New Haven, Connecticut, United States Job Level : Leadership Designation : President & Chief Scientific Officer at Paratus Sciences
URL has been copied!

Insights For Selling To Mark

During A Call Or A Meeting

DO's

  • Come across as a trustworthy professional and be respectful, they usually know their game
  • Let them know of potential risks but suggest mitigation methods alongside
  • Use phrases like 'your team deserves', 'best in class' etc.

DONT's

  • Don't take their patience for granted, avoid long-winding sermons
  • Don't go over them unless you are left with no other option
  • Don't shy away from asking hard questions, but be extra polite

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Mark is

  • Strong proof of impact and their conviction will matter the most, but they wouldn't want to act unilaterally either
  • Will you ever get a clear answer from Mark

  • They will say no if they are not convinced but you will have to prompt them.

Insights For Deal Planning

    How fast (or slow) will Mark move?

  • They will want to understand things well but can move fast once they have a clear picture.
  • Can Mark take some risk or not?

  • They have good risk tolerance but are likely to think it through once or twice.

You And Mark

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.